Introduction
============

Precision Medicine (PM) refers to the targeting of therapies according to an individual's, genetics, lifestyle or environment and holds immense promise to improve population health outcomes ([@B34]). A branch of precision medicine, pharmacogenomics (PGX) is the study of genetic information to determine individual response (e.g., efficacy/toxicity) to pharmaceutical agents with the goal of developing safe and effective medications and dosage that can be tailored based on an individual's genetics ([@B38]; [@B14]). In order to draw conclusions about gene interactions and genetic variation within and across ancestries, substantial and diverse patient data are needed ([@B30]; [@B34]). To date, most PGX participants are of European ancestry ([@B52]). However, African Americans have greater genetic variation than European populations, therefore, results from existing PGX studies may not be as predictive in African American populations ([@B32]; [@B52]). Under-representation of African American populations impairs the ability to translate PGX findings into clinical care, and will ultimately result in increased health disparities ([@B52]).

The challenge of recruiting minority populations likely stems from historic and contemporary mistreatment. For example, the Tuskegee Syphilis study has had a lingering effect on African Americans trust of medical institutions and research ([@B17]). In addition to historic mistrust related to clinical research more broadly, genomic studies are further problematized due to concerns about personal identification, disenfranchisement stemming from genomic-based policies, and the potential threat of eugenics ([@B29]). Furthermore, concerns about the inability for genomic research to address issues of social justice, and potentially exacerbate issues of health disparities remain ([@B29]). Although few studies have examined the recruitment of African Americans to PGX studies, several have reported African American recruitment for genetic studies or biobanks (which we hereinafter refer to as genomic studies for simplicity).

Prior studies have reported demographic differences, for example, that African Americans are less likely to participate in research that includes a DNA sample or a biopsy compared with whites ([@B13]; [@B47]). However, other studies have reported conflicting findings related to demographic factors influencing participation. One study related to prostate cancer genomics compared African American participants with white participants and found African American participants were younger, less educated, lower income, and less likely to be married compared with white participants ([@B51]). However, a different study found that African American women who provided a saliva sample for genomic research were older, regularly took a multivitamin, had a physician visit in the previous year, and reported a history of breast colorectal, or cervical screening compared with African American women who did not provide a saliva sample ([@B1]). While demographic differences are useful in the categorization of participants, they do not provide useful insight for recruitment efforts.

Literature on recruitment efforts often describe community-based approaches (CBA) to engage participants in genomic studies by emphasizing intentional and meaningful community member engagement throughout the research process ([@B28]; [@B58]; [@B35]; [@B48]; [@B45]). However, CBA focus on broad methods for recruitment and less on message content. Existing studies also have reported on the use of educational materials and seminars to improve African American recruitment ([@B56]; [@B23]; [@B54]; [@B53]). Studies found pre-post increases in knowledge about genomic studies, more favorable attitudes ([@B50]) and less negative affect ([@B35]) after receiving an educational intervention. However, random control trials and other studies employing pre-post assessment found no changes in attitudes about genomic research because of educational interventions ([@B56]; [@B23]). Such findings are not surprising because attitudes do not correlate with knowledge, but are shaped by values and beliefs ([@B20]; [@B42]; [@B16]). Therefore, recruitment messages which address beliefs and attitudes related to participation in PGX studies, in addition to providing education, may speak more directly to African Americans' concerns, and may more consistently improve recruitment efforts ([@B55]).

Existing literature regarding African Americans' beliefs and attitudes about genomic studies is disparate, and sometimes conflicting. Aggregating existing information provides an opportunity to reflect on current findings and potentially guide recruitment message strategies. Therefore, the objective of this paper is to systematically review qualitative and quantitative literature on African Americans' beliefs and attitudes about genomic studies that may influence their decision to participate. We synthesized results from this review to highlight opportunities for the design of genomic study recruitment messages.

Materials and Methods {#s1}
=====================

Study Design
------------

Studies that provided insight regarding African Americans' beliefs and attitudes toward participation in biobanks or genomic studies (inclusive of genetic or PGX) were included in this review. We focused on biobank and genomic studies because, to the best of our knowledge, no studies have exclusively explored African Americans' beliefs and attitudes about PGX. Qualitative and quantitative studies with original empirical data were included, but conference abstracts, reviews, commentaries, editorials, legal opinions, letters to the editors, case studies, dissertations, and thesis studies were excluded. Given the potential influence of historical context, we excluded studies conducted outside the United States. We were interested in genetic studies that may be able to provide information on the treatment of chronic adult onset conditions; therefore, we excluded studies related to behavioral, developmental, or mental health genomics because we believed contextual factors (e.g., stigma, environment) could impact the results of such studies. We also excluded studies that explored medical professionals' attitudes or beliefs about genomic studies because, while valuable, their attitudes and beliefs may be influenced by their additional education and training. We excluded studies that included less than 13% African Americans as a proportion of the total sample, which is consistent with the proportion of African Americans in the United States population. Finally, we excluded studies in which we could not distinguish African Americans' responses from the responses of other study participants. Genomic studies have been conducted over a relatively limited period; therefore, we included all studies accepted for publication up to July 25, 2018 in this review.

Information Sources and Search
------------------------------

A study team member worked with a University librarian and searched PubMed, Scopus, Web of Science, Embase, and Google Scholar for relevant citations. The search string was as follows: "African American" OR Black AND "genetic research" OR "pharmacogenomics research" OR "genomic research" OR "personalized medicine" OR "precision medicine" AND "study recruitment" OR "research participation." The initial search returned 1,179 total citations: 15 from PubMed, 14 from Scopus, 133 from Web of Science, 26 from Embase, and 990 from Google Scholar. After consolidating the lists, we removed 109 duplicate citations, for a final sample of 1,070 citations.

Study Selection
---------------

We screened studies for eligibility by conducting a review of the study titles, followed by an abstract review, and finally a full text review. Reviewers were instructed to be conservative in their exclusion; when uncertain, the study was retained. One study team member conducted the review of titles and excluded those that did not meet eligibility criteria. A second team member reviewed 20% of the titles to confirm exclusion criteria reliability. Kripendorf's α = 0.73 was achieved, an acceptable level of reliability ([@B37]). Next, two study team members split the remaining abstracts evenly for review, and excluded those which did not meet eligibility criteria. Twenty percent of the abstracts overlapped for reliability calculation, and α = 0.86 was achieved. Finally, one study team member reviewed 92% and another study team member reviewed 28% of full text and excluded those that did not meet eligibility criteria. Twenty percent of the full text overlapped to calculate reliability, and α = 0.85 was achieved.

Data Analysis
-------------

One study team member reviewed the final studies included in the analysis to extrapolate information including the study design, the population setting, the total sample size, the sample race, and age. Two study team members conducted thematic analysis of the articles using MAXQDA to manage the data ([@B59]).

Results
=======

Of the 1,070 total titles screened, we removed 292 based on the title review, 558 based on the abstract review, and 197 based on the full text review, for a final sample of 24 articles (see [Figure 1](#F1){ref-type="fig"}).

![Exclusion process.](fgene-10-00548-g001){#F1}

Review of Studies
-----------------

Our review of the literature ([Table 1](#T1){ref-type="table"}), identified tensions in African Americans' beliefs and attitudes about genomic research. The overarching theme of trust (or lack thereof) was present across studies, and influenced subsequent attitudes about genomic research and participation. However, even with concerns about trust, African Americans believed their participation in genomic studies was critical. These negative and positive beliefs informed their attitudes about participation in genomic studies. What follows is a summary of the literature highlighting tensions between distrust and the value of their participation.

###### 

Studies included in Review.

  References   Study design                                                     Setting and population                                                                                                  Sample size                                                                                                           n(%) AA^∗^
  ------------ ---------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------
  [@B2]        Qualitative focus group study                                    Southeastern United States General population                                                                           *N* = 215                                                                                                             118(55)
  [@B4]        Quantitative cross-sectional survey study                        Orlando, Florida at The Links, Incorporated 38th National Assembly Female Links Members                                 *N* = 381                                                                                                             381(100)
  [@B5]        Mixed methods; CBPR and focus group study                        Wisconsin Genomic Initiative Community members                                                                          *N* = 21                                                                                                              21(100)
  [@B6]        Mixed methods telephone survey                                   North Carolina North Carolina Colorectal Cancer Study Database                                                          *N* = 801                                                                                                             153(19%)
  [@B7]        Quantitative cross-sectional survey study                        Washington DC Metro Area Community members                                                                              *N* = 304                                                                                                             304(100)
  [@B8]        Qualitative exploratory study                                    Central Harlem, New York Community members                                                                              *N* = 46                                                                                                              39(89) 4(9) AA/ Hispanic 1(2) AA/ Native American
  [@B10]       Mixed methods; focus group and cross-sectional survey study      Southeast/Southwest Washington, DC Community members                                                                    Focus groups (*n* = 41) Surveys (*n* = 321)                                                                           Focus groups 41(100) Surveys 234(73)
  [@B11]       Quantitative cross-sectional survey study                        South Carolina State University Students                                                                                *N* = 200                                                                                                             200(100)
  [@B12]       Qualitative focus group study                                    St. Louis, Missouri; Prostate Cancer Community Partnership Men with prostate cancer                                     *N* = 70                                                                                                              70(100)
  [@B15]       Mixed methods; focus group and cross-sectional survey study      Niagara Falls, New York Community members and Key informants                                                            Key informant interviews (*n* = 9) Community focus groups (*n* = 21) Staff focus group (*n* = 5) Surveys (*n* = 64)   Community focus groups 13(62) Surveys 34(53)
  [@B19]       Mixed methods; computer assisted telephone interviewing system   Patients from Duke University, Johns Hopkins, University of Arizona, University of North Carolina, University of Utah   *N* = 1,193                                                                                                           192(16)
  [@B21]       Quantitative survey study                                        Detroit, Michigan Community members                                                                                     *N* = 78                                                                                                              78(100)
  [@B22]       Quantitative survey study using vignettes                        National sample of AA                                                                                                   *N* = 510                                                                                                             510(100)
  [@B25]       Qualitative semi-structured interview and focus group study      North Carolina Community members                                                                                        Focus groups (*n* = 46) Interviews (*n* = 9)                                                                          55(100)
  [@B27]       Qualitative semi-structured interview study                      North Carolina Community members                                                                                        *N* = 91                                                                                                              72(79)
  [@B33]       Quantitative cross-sectional survey study                        Kansas City, Kansas Community members                                                                                   *N* = 169                                                                                                             169(100)
  [@B36]       Qualitative focus group study using trigger videos               Northern California Patients at a large multispecialty practice                                                         *N* = 122                                                                                                             23(18.9)
  [@B39]       Qualitative focus group study using trigger videos               Northern California Patients at a large multispecialty practice                                                         *N* = 122                                                                                                             23(18.9)
  [@B41]       Qualitative focus group study                                    Tampa, Florida Community members                                                                                        *N* = 95                                                                                                              33(34.7)
  [@B44]       Quantitative survey study                                        National sample of AA                                                                                                   *N* = 1,033                                                                                                           1,033(100)
  [@B43]       Qualitative focus group study                                    Philadelphia, Pennsylvania                                                                                              *N* = 91                                                                                                              91(100)
  [@B49]       Qualitative focus group study                                    Buffalo, New York Female breast cancer survivors                                                                        *N* = 14                                                                                                              14(100)
  [@B57]       Qualitative focus group study                                    Lenoir County, North Carolina Community members                                                                         *N* = 25                                                                                                              19(76)
  [@B60]       Qualitative focus group study                                    Jackson, Mississippi Community members                                                                                  *N* = 140                                                                                                             140(100)
                                                                                                                                                                                                                                                                                                                              

∗

AA, African American.

Distrust
--------

We found a shadow of historic and continued injustice cast across studies. Distrust was ubiquitous in all facets of the research enterprise and extended from members of the research and medical communities ([@B57]; [@B12]; [@B36]), to medical or research institutions ([@B12]; [@B36]), and the conduct of research and science in general ([@B57]). The Tuskegee Study of Untreated Syphilis frequently functioned as a historical referent for the distrust of biomedical research, particularly among African Americans ([@B25]; [@B2]; [@B8]; [@B36]). One study found African Americans were significantly more concerned that something like Tuskegee could happen again than white participants ([@B21]). More specific to genetics, revelations about Henrietta Lacks, and more recent and local race-related abuses by researchers, raised concerns about trust, privacy and the benefits of genomic studies ([@B5]; [@B12]; [@B36]; [@B39]). The impact of race-related injustice was apparent in two multi-race studies that found distrust was more salient among African American participants compared with their white counterparts ([@B6]; [@B21]). The salience of race in historic injustices in the United States raised suspicions about researchers' intentions, and the potential for race-based research to be used for maleficence ranging from racial discrimination to eugenics, or even genocide ([@B5]; [@B27]; [@B36]).

Distrust often was tied to fears about study processes and outcomes. Most frequently mentioned were fears of being experimented on or treated as a "guinea pig" or "lab rat" ([@B25]; [@B49]; [@B41]; [@B5]; [@B15]; [@B21]; [@B60]), as was fear of exploitation ([@B43]; [@B5]). Several studies revealed beliefs that research is conducted at the expense of African Americans for the financial profit of those in power ([@B36]; [@B39]), or to provide more effective treatments to white or privileged individuals ([@B41]; [@B22]). Both African American and white participants in one study raised concerns about the possibility that genetic research could be used to discriminate against certain groups of people, with significantly more African Americans reporting that their concern about potential discrimination would influence their willingness to provide a blood sample for research ([@B19]). Personal experiences with racial discrimination, and witnessing expanding health disparities in spite of medical advancements, added to beliefs that the medical and research communities were not trustworthy ([@B5]). Among African Americans, increased distrust was significantly associated with reduced likelihood of biobank participation ([@B44]; [@B22]).

Despite concerns about trust and associated fears about participation, participants' relationship with medical research was complicated ([@B43]). Tensions existed between distrust of medical research and beliefs that African American participation in research is imperative ([@B2]; [@B49]; [@B43]; [@B15]; [@B21]). In particular, participants described the necessity of African American participation in order to determine the efficacy and optimal dosing (i.e., PGX) and find more effective ways to treat and prevent diseases which frequently impact their race ([@B2]; [@B5]; [@B15]). In one study, neither concerns about exploitation nor distrust of medical research were associated with willingness to donate biological specimens for research ([@B21]).

In contrast, some studies found African American participants trusted medical research and biobanks, and were favorable toward medical research ([@B21]; [@B60]; [@B7]). More recent studies assessing African American community members' knowledge, beliefs, and attitudes about medical and genomic research found study participants did not believe they would be taken advantage of or harmed by research focused on minorities ([@B7]; [@B33]). Female members of The Links Incorporated (a not-for-profit African American service organization) who believed research conducted in the United States was ethical were more willing to participate in genomic studies ([@B4]).

The overarching theme of distrust was present in most, but not all studies. Even among those with high levels of distrust, the importance of African Americans' participation in medical and genomic research was recognized. This dichotomy may explain why some studies found high levels of distrust and others did not. Participants' divergent views may underlie an attempt to reconcile beliefs about distrust of medical research with the importance of their participation in medical research to avoid cognitive dissonance.

Community Engagement
--------------------

Participants described community engagement as one strategy to overcome distrust. Community members and leaders described how researchers often entered their community to obtain something from them, and then simply left ([@B5]). Such interactions left the community feeling used, disrespected and engendered continued distrust ([@B5]). Failing to engage community members prior to conducting studies was viewed as a barrier ([@B25]), whereas genuine engagement, care and communication were viewed as facilitators that created trust ([@B60]). "Authentic collaboration" is desired which means that researchers: (1) engage with community leaders and the community at the start of the project before major decisions are made, (2) ensure proper resources are available, (3) give credit to the communities, (4) maintain community engagement beyond the study, and (5) share study outcomes ([@B5]; [@B8]). Participants did not desire frequent contact, but they wanted to know how their participation contributed to the advancement of science ([@B8]). Similarly, participants in a focus group study recommended working early on in the research process to improve relationships between institutions and community members citing existing strong relationships with local community hospitals as an example ([@B36]).

Awareness and Knowledge
-----------------------

Awareness and knowledge of genomics, or a desire to learn more were associated with favorable attitudes toward genomic studies and/or intentions to participate ([@B25]; [@B49]; [@B8]; [@B33]). Conversely, lack of education, understanding, awareness or knowledge were associated with less favorable attitudes and lower intentions to participate ([@B25]; [@B2]; [@B49]; [@B57]; [@B12]). Participants noted that information about research studies was not readily available in their communities, or that African Americans are often not approached or asked to participate ([@B12]).

Participants described opportunities to overcome low levels of awareness, such as providing educational sessions to ensure informed participation of African Americans ([@B5]). Participants in another study suggested that researchers could learn as much from the community as the community could learn from researchers, and advocated for bidirectional educational efforts be bidirectional ([@B5]). Similarly, research targeting the African American community was viewed as an opportunity for collaboration between researchers and community members ([@B8]). Tying together trust and education, participants suggested that one way to prevent mistreatment of African Americans was for them to request additional information about research studies during recruitment ([@B2]; [@B43]). Given this finding, researchers should anticipate that African Americans will have a greater need for information about study procedures than white participants do.

Process of Study Conduct
------------------------

Across studies, African Americans described their attitudes and beliefs about particular aspects of the research process including research team members and/or the associated institution, study procedures and safeguards, participation risk and compensation. We describe each category next.

Face of the Study
-----------------

African Americans reported in two studies that they were more likely to participate in research conducted by Historically Black Colleges (HBC) ([@B25]; [@B11]). HBCs were viewed as more trustworthy, and participants believed the involvement of HBCs would ensure results and benefits from their participation would be returned to the African American community ([@B25]). Additionally, African Americans want to see African American physicians and/or researchers in leadership roles on the research team ([@B25]; [@B2]; [@B5]; [@B44]; [@B7]). It was believed researchers from shared racial backgrounds would be more likely to understand relevant cultural beliefs and experiences, and were viewed as more trustworthy ([@B25]; [@B2]; [@B5]; [@B44]; [@B7]; [@B36]). In two studies African Americans reported that they were more likely to participate if the investigator was African American ([@B11]; [@B44]), and one study found a decreased likelihood of participation if the study was conducted by a predominately white college or a white investigator ([@B11]).

Similarly, participants across several studies preferred information about genomic research or specific studies be delivered by African Americans ([@B11]; [@B10]), particularly if the study was race specific ([@B44]). Participants reported more favorable attitudes toward research, and an increased likelihood of enrollment when the study was introduced by a trusted other such as their physician, friends, family members, and/or community leaders ([@B25]; [@B11]; [@B12]). Participants suggested that hearing about the research study within their community, and knowing others in their community who were involved in the study, would increase their likelihood of participation ([@B12]).

Study Procedures and Safeguards
-------------------------------

Given past injustices, African Americans held significant concerns about the use and accessibility of their data by other individuals or institutions. Due to racism and possible malevolent intent, across studies African Americans wanted to know specifically how their biological material might be used ([@B5]; [@B21]). Not knowing specifically how the specimen would be used was a barrier to participation ([@B10]). There were concerns about surreptitious use of genetic material for surveillance, to deny rights and privileges, in criminal investigations, and for other uses beyond the purpose of their original consent ([@B25]; [@B5]; [@B8]; [@B36]). In addition to the aforementioned concerns, participants in one focus group study specifically mentioned concerns related to identity, cloning, and the use of their sample after death ([@B39]). In addition, not knowing who would have access to their personal information, and who might obtain access to their personal information (e.g., other medical entities like insurance companies) raised concerns, and in some cases, significantly decreased likelihood of participation ([@B49]; [@B44]; [@B60]; [@B22]). Across studies, transparency of study procedures and clear descriptions about safeguards to protect participant privacy were determined essential for participation. Specifically, African Americans want transparency and to know as much as possible about the purpose and rationale for the study, how their specimen would be used and by whom, and the safeguards in place to protect their privacy ([@B10]; [@B21]; [@B57]; [@B36]). Furthermore, continued and ongoing communication about changes to study protocols, or changes to sample access, and the specific studies for which their sample would be used was important, as was maintaining the option to opt in or out of particular studies ([@B36]; [@B39]).

Participation Risk
------------------

One study identified that beliefs about the risk of participation were negatively associated with willingness to participate ([@B4]), but another study found concerns about the risk of participation was only a consideration when making participation decisions ([@B43]). Another study found African Americans were specifically worried about the possible contamination of equipment used for biospecimen collection ([@B21]). Aside from risk, concerns about procedures primarily focused on invasiveness. Studies found participants least preferred studies where methods were viewed as invasive ([@B7]), and were more favorable toward participating in studies they believed were less invasive in terms of procedure, privacy, and resources ([@B25]; [@B11]; [@B7]). Although one study found blood donation for participation in a genomic study to be minimally invasive ([@B43]), other studies identified fear of needles or the donation of blood as a barrier to study participation ([@B49]; [@B10]; [@B12]).

Concerns about invasiveness included the expenditure of resources, specifically, cost and time. Participants in one study raised concerns about the potential personal costs of participating including costs associated with blood draws and genetic analysis ([@B57]). Possible sustained participation in a longitudinal study evoked questions about the number of tasks and time required of participants ([@B25]; [@B43]); participants were more favorable about participating in studies which only lasted a short period of time ([@B44]). Participants viewed the distance they had to travel for study participation as a barrier to participation ([@B43]; [@B7]). Any perceived expense to the participant such as cost or time for participation, including time that would be taken from work ([@B60]; [@B57]) and transportation issues ([@B44]; [@B22]) were barriers to participation, unless compensation could be provided ([@B7]).

Compensation
------------

African Americans expected compensation for participants' time for any study that required any type of time commitment, including travel. Compensation for such expenses were believed to increase participation ([@B15]; [@B57]; [@B7]; [@B12]; [@B33]), and in some cases, African Americans suggested profit sharing as a means for compensation ([@B5]; [@B33]). However, across studies it was noted that the form of compensation did not always need to be direct participant payment. African Americans suggested that food, gas cards, healthcare and/or medication ([@B25]; [@B21]; [@B12]), and even individual research results could be provided as a form of compensation ([@B57]; [@B33]). Indeed, some studies found failure to provide research results to participants would prevent African Americans from participating ([@B44]; [@B22]).

Individual Level Benefits and Drawbacks of Study Participation
--------------------------------------------------------------

African Americans' interest in participating in genomic studies often was driven by beliefs about benefits for themselves, family members, or future generations. In some cases, individual benefit was broadly or unclearly defined ([@B43], [@B44]; [@B57]; [@B33]). In other studies, individual benefit included the belief that participation in research meant they would receive better health care ([@B4]). Participants across several studies believed they would derive individual benefit by learning more about their genetic risk, which, depending on the results, could act as a motivator for making positive lifestyle changes ([@B5]; [@B57]). Studies conducted with affected participants, or those already at risk for a specific disease, found increased interest in participation when the study could provide knowledge about the particular condition, for example, cancer ([@B49]; [@B44]; [@B22]), asthma ([@B33]), cardiovascular disease, or type 2 diabetes ([@B57]).

Aside from personal benefit, African Americans across studies believed participation in genomic or biobank studies could provide insight into disease that would ultimately benefit their family members or future generations ([@B49]; [@B43]; [@B10]; [@B60]; [@B57]; [@B12]; [@B36]). They also suggested benefits to family members or future generations could be indirect or much further into the future, such as helping researchers develop medicine that may be used by future generations ([@B10]).

Notably, two studies found participants did not believe there would be a personal benefit from participating in a research study, and did not believe they would be a benefactor of research outcomes ([@B22]; [@B12]). African Americans believed they were unlikely to benefit personally from medical advancements due to insurance discrimination and the out of pocket costs associated with new pharmaceutical treatments ([@B22]; [@B39]). In some cases, African Americans believe harm could come from finding out about a medical condition that they did not want to know about. As a result, in some studies, learning about personal genetic information was identified as a barrier to participation ([@B49]; [@B60]; [@B57]; [@B12]; [@B33]).

At the Community Level
----------------------

The potential for genomic or biobank studies to improve health outcomes for their community was embraced by participants ([@B19]; [@B43]; [@B5]; [@B60]; [@B8]). Several studies highlighted participants' beliefs that African American participation in medical research, and genomic research in particular, is essential as a means to address health issue of traditionally underserved populations as a means to reduce health disparities ([@B49]; [@B43]; [@B27]; [@B57]). African Americans in one study held the belief that their participation in today's research would facilitate personalized medicine and more targeted prevention and treatment options for disease, for future generations of African Americans ([@B5]). While African Americans were favorable toward race specific studies designed to improve health outcomes for their own race ([@B19]; [@B49]; [@B44]; [@B60]), results from one study found participants felt such studies were more likely to take advantage of or hurt minorities ([@B33]). Further, African Americans suggested that despite their participation and advances in medicine, they believed study results were unlikely to reach their community as a result of historic barriers to medical care ([@B41]). As a solution, African Americans suggested that any prevention or treatment innovations resulting from African American participation must be accessible and affordable for those community members ([@B5]; [@B22]). Yet, concerns were raised about whether genomic studies could address social determinants of health that are typically responsible for poor health outcomes, and are often ignored ([@B5]).

Related to the belief that their participation could benefit their community, favorable views about participation in genomic studies or biobanks most frequently stemmed from altruistic beliefs. Participants believed participation in genomic studies would help future patients or people in general ([@B43]; [@B57]; [@B36]). Caring for others and the benefit of participation to society were central to motivating participation ([@B4]; [@B33]), despite concerns about trust ([@B2]).

Discussion and Conclusion
=========================

Given favorable attitudes, but low participation rates, culturally appropriate and ethical messages about PGX studies that facilitate recruitment of African Americans are needed ([@B22]). Trust has often been cited as the leading barrier to African American participation in health-related research ([@B18]; [@B40]; [@B26]; [@B33]). Consistently, our review found that distrust in the healthcare system, medical research, organization, and researchers is a commonly held belief by many African Americans ([@B2]; [@B6]; [@B21]; [@B44]; [@B8]; [@B57]; [@B22]; [@B12]). We forward several suggestions to overcome distrust (see [Table 2](#T2){ref-type="table"}). First, meaningful and intentional community collaboration can demonstrate value and meaning for African American participants ([@B60]). Indeed, a systematic review conducted by [@B32] identified community-based strategies, such as engaging community leadership, as one method for improving recruitment of African Americans into genomic research. However, results from our review suggest researchers must move beyond simply contacting community leaders at the time of the study. Instead, researchers should engage in what participants called "authentic collaboration" from before the start of the research study and extending after the study as a means to foster trust, demonstrate respect and honor the value of community contributions ([@B5]; [@B8]). These findings are consistent with the success of other studies, which have used CBA as a method to improve recruitment of African Americans ([@B28]; [@B58]; [@B35]; [@B48]; [@B45]).

###### 

Summary of Beliefs and Attitudes and Message Design Opportunities.

  Beliefs and attitudes                                                                                               Message design opportunities
  ------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Barriers to recruitment**                                                                                         
  **Distrust** -- of researchers, universities or health care organizations, science and medicine at large            1.Establish relationship with community members prior to beginning research study and engage them in recruitment design efforts2.Consider engaging African American community members, including other research participants and community health care workers, as the senders/disseminators of recruitment messages3.Engage African American study team members as senders/disseminators of recruitment messages4.Provide a clear description of study purpose, procedures, who will be able to access their data and privacy safeguards in place5.Messages about the use of participant data should be clearly detailed6.Describe how information from the study may impact health care for the African American population7.Any and all forms of compensation should be clearly described in any study asking for participants' time, including travel time
  **Lack of Education** -- about research studies and genetics created less favorable attitudes about participation   1.Outreach efforts should focus on providing more information about genomic studies more broadly2.Delivering in-person education may be advantageous because researchers can address additional questions or concerns on the spot, and at the same time engage with and learn from the population3.Combine educational messages with messages that describe use of data and standard privacy protections that are in place4.Messages should provide detailed information about research purpose, processes and outcomes
  **Facilitators of recruitment**                                                                                     
  **Participation** -- beliefs that African American participation is necessary and essential                         1.Messages should emphasize the importance of African American participation for their community2.When appropriate, messages should describe any potential individual level benefit from participation in the study3.When appropriate, messages should describe any potential future benefit to family members4.When appropriate, messages should describe any potential future benefit for the African American community5.Messages about altruism should be included in recruitment efforts
                                                                                                                      

Our review also identified lack of knowledge or awareness about genomic studies as an overarching barrier ([@B25]; [@B31]; [@B56]; [@B49]; [@B12]). However, educational interventions have demonstrated little impact on attitudes or beliefs, thus suggesting messages that address existing attitudes and beliefs in addition to providing education may be more effective at addressing African Americans' concerns about participation in genomic studies ([@B56]; [@B23]). Furthermore, it could be argued that beliefs about the trustworthiness of research scientists or institutions ([@B41]; [@B15]; [@B21]; [@B60]) impact African Americans' expectations for research participation. For example, African Americans concerns about being experimented on or exploited explain why they want complete transparency about study protocols and data sharing practices ([@B10]; [@B21]; [@B57]). As such, messages that are transparent and clearly describe the study protocol may reduce mistrust as a barrier. Based on our review, messages for African Americans about genomic studies should provide substantial information about the study purpose and procedure and describe processes and measures in place to safeguard their privacy. Previous research found that messages which intentionally highlight procedures and security are more likely to overcome concerns related to privacy and outcomes ([@B46]; [@B18]; [@B40]; [@B26]; [@B33]).

Contrary to the belief that minority populations are not interested in participating in research studies, our review found African Americans were highly interested in participating ([@B61]; [@B24]; [@B33]). Studies in our review indicated African Americans believed their participation in medical research was crucial for the advancement of science ([@B2]; [@B43]; [@B15]; [@B21]). Thus, researchers should devote more attention to facilitators of African American participation in medical research. Specifically, as identified in our review, messages that highlight altruism or benefit for one's community and recognize the importance of including minority populations may promote participation in clinical studies of African Americans ([@B18]; [@B26]; [@B33]).

Ultimately, one goal of PM research is to reduce health disparities ([@B9]; [@B34]). In particular, PGX uses personal genomic data to inform optimal tailoring of pharmaceutical agents to prevent adverse drug interactions ([@B52]). Despite the individualized focus of PGX, efforts require a population-based approach to better understand inter-population and intrapopulation diversity ([@B3]; [@B34]). This review drew upon existing literature to provide a consolidated overview of African American's beliefs and attitudes toward genomic research. This information can inform recruitment strategies and messages that may increase African American participation in genomic studies, and PGX studies in particular. Future research testing the message strategies identified in this review are needed to continue to understand best practices for communicating genomic research with the African American population. Additionally, future studies should explore African Americans' beliefs and attitudes regarding PGX studies. Such knowledge may contribute to the advancement of PM among minority populations.

Author Contributions
====================

CS, SR, and MP conceptualized the study. CS, SR, and CM-F devised the methods, conducted the literature search, reviewed the literature, and conducted the analysis. CS and SR drafted the manuscript. MP reviewed and edited the manuscript.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This study was supported by U54 MD010723 African American Cardiovascular pharmacogenetic CONsorTium (ACCOUNT): discovery and translation.

[^1]: Edited by: Jessica Nicole Cooke Bailey, Case Western Reserve University, United States

[^2]: Reviewed by: Satyanarayana M. R. Rao, Jawaharlal Nehru Centre for Advanced Scientific Research, India; Suzette J. Bielinski, Mayo Clinic, United States

[^3]: This article was submitted to Applied Genetic Epidemiology, a section of the journal Frontiers in Genetics
